Discharge Medication Use Post-Operatively in GU Cancer Patients
ConditionGenitourinary Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorWake Forest University Health Sciences
About this trial
The main purpose of this research study is to determine the amount of opioids that are taken after discharge following a cystectomy, nephrectomy (partial or total), or prostatectomy surgeries via a 30-day post- discharge opioid use and disposal survey. We will also evaluate the impact of an opioid disposal education pamphlet on proper disposal of unused opioids.
Eligibility criteria
Qualifiers
Written informed consent and HIPAA authorization for release of personal health information.
Age ≥ 18 years at the time of enrollment
Scheduled to undergo surgical cystectomy, partial or total nephrectomy or prostatectomy for a cancer diagnosis.
Ability to read and understand the English and/or Spanish language.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Opioid Medication Disposal Education
Treatment groups
684 Participants
are divided into 2 treatment groupsSponsors and collaborators
Wake Forest University Health Sciences
Lead sponsor
Atrium Health Levine Cancer Institute
Collaborator
Source ClinicalTrials.gov